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background: The three azoospermia factor (AZF) regions of the Y chromosome represent genomic niches for spermatogenesis
genes. Yet, the most distal region, AZFc, is a major generator of large-scale variation in the human genome. Determining to what extent
this variability affects spermatogenesis is a highly contentious topic in human reproduction.
methods: In this review, an extensive characterization of the molecular mechanisms responsible for AZFc genotypical variation is under-
taken. Such data are complemented with the assessment of the clinical consequences for male fertility imputable to the different AZFc var-
iants. For this, a critical re-evaluation of 23 association studies was performed in order to extract unifying conclusions by curtailing
methodological heterogeneities.
results: Intrachromosomal homologous recombination mechanisms, either crossover or non-crossover based, are the main drivers for
AZFc genetic diversity. In particular, rearrangements affecting gene dosage are the most likely to introduce phenotypical disruptions in the
spermatogenic proﬁle. In the speciﬁc cases of partial AZFc deletions, both the actual existence and the severity of the spermatogenic defect
are dependent on the evolutionary background of the Y chromosome.
conclusions: AZFc is one of the most genetically dynamic regions in the human genome. This property may serve as counter against
the genetic degeneracy associated with the lack of a meiotic partner. However, such strategy comes at a price: some rearrangements
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represent a risk factor or a de-facto causative agent of spermatogenic disruption. Interestingly, this precarious balance is modulated, among
other yet unknown factors, by the evolutionary history of the Y chromosome.
Key words: Y chromosome / AZFc / partial AZFc deletions / spermatogenesis / male infertility
Introduction
The role of the Y chromosome (Y) as a genomic niche for genes
involved in male gamete production has been appreciated since the
mid 1970s. In their seminal paper, Luciano Tiepolo and Orsetta
Zuffardi convincingly argued for the existence of an azoospermia
factor (AZF) in the long arm of the Y (Yq) (Tiepolo and Zuffardi,
1976). According to the authors, this factor represented a key
genetic determinant for spermatogenesis since its deletion was associ-
ated with a lack of sperm in the ejaculate. Owing to the structural
complexity of the Y chromosome, a more precise identiﬁcation of
the AZF took 30 years to be achieved. Indeed, large-scale molecular
screening for Y chromosome microdeletions (i.e. those not identiﬁable
via conventional cytogenetic techniques) revealed that such determi-
nants displayed a tripartite organization (Vogt et al., 1996). Thus,
AZFa, AZFb and AZFc were established as the Y chromosome
regions regulating spermatogenesis. Subsequent DNA sequencing
approaches demonstrated that these regions harbour a total of 12
different genes/gene families (Kuroda-Kawaguchi et al., 2001; Tilford
et al., 2001; Skaletsky et al., 2003).
In clinical terms, the importance of the AZF regions is paramount as
deletions in these domains are one of the most frequent genetic
causes of spermatogenic failure (Simoni et al., 2004). Of the three
AZF regions, none has been the source of more vigorous debate
than AZFc. If the controversy could be summed up in one word,
that would be variability. Indeed, AZFc displays signiﬁcant variation
in terms of genomic architecture across the male population. Yet,
the phenotypical consequences for spermatogenesis of some of
these variants are unclear. In this regard, the aim of the present
review is two-fold. First, the drivers for AZFc genetic diversity will
be addressed via a comprehensive analysis of the molecular
mechanisms shaping this region. Secondly, the impact of this variation
on male fertility will be discussed, with particular care being given to
contentious topic of partial AZFc deletions. With this strategy, we
hope to present a more uniﬁed picture of one of the most divisive
aspects of reproductive genetics.
Methods
The present manuscript consists of an extensive narrative review coupling
a critical discussion of available studies with newly generated data. Pre-
viously published reports were collected and analysed by performing mul-
tiple searches of the MEDLINE database between September 2004 and
December 2009. Generic search terms for the AZFc region were
employed, with reports deemed of signiﬁcant relevance being included
in this manuscript.
For the integrated evaluation of partial AZFc deletion association
studies, 23 reports were selected based on the following criteria: (i) pub-
lished in international peer-reviewed journals; (ii) listed on National Center
for Biotechnology Information databases and accessed using ‘AZFc OR gr/
gr’ as the queried term; (iii) fully written in English; (iv) designed as
association studies selecting men with normal spermatogenic proﬁles
(presumed or veriﬁed) as controls and men with spermatogenic impair-
ment as cases; (v) sample size .50 men for either group; (vi) employing
sequence tagged site methodology with diagnostic power for partial AZFc
deletions; (vii) results sorted by partial deletion pattern; (viii) published
between 2003 and 2008. After selection, a careful evaluation of methodo-
logical design speciﬁcities was performed in order to recalculate, whenever
necessary, deletion rates using the most homogenous criteria.
Genetic organization of the AZFc
sequence: the amplicon as
building block
The three AZF regions were originally deﬁned based on the associ-
ation of speciﬁc spermatogenic disruption phenotypes to precise Y
chromosome deletion intervals (Vogt et al., 1996). In the case of
AZFc, the observed phenotype was hypospermatogenesis (reduced
sperm production). It was later demonstrated that this functional indi-
viduality was not reﬂected at the genomic level, as the proximal end of
the AZFc region overlapped with the distal end of AZFb (Repping
et al., 2002). Validation for the inherently functional deﬁnition of
AZFc has been warranted by the development of Y microdeletion
screening programmes in the male population. As discussed by
several authors, these have produced convincing evidence that AZFc
deletions are responsible for marked spermatogenic defects (Vogt,
2005; Krausz and Degl’Innocenti, 2006; Noordam and Repping,
2006; Sadeghi-Nejad and Oates, 2008; and references therein). In
fact, men with such deletions display sperm concentrations largely
under 1 million sperm/ml (normal value: .20 million sperm/ml;
Vogt et al., 1996; Oates et al., 2002; Simoni et al., 2008). Extended
clinical experience has also revealed that AZFc deletions account for
60% of all recorded AZF deletions, further accentuating their signiﬁ-
cance (Ferlin et al., 2007b; Simoni et al., 2008). Suitably, the genetic
disruption of AZFc is generally perceived as a key concern for male
reproductive health.
The assembly of the full AZFc sequence represented an undisputed
milestone in the study of the Y chromosome. In retrospect, sequen-
cing this 3.5 Mb stretch of Yq euchromatin epitomized the proverbial
opening of Pandora’s box: AZFc was shown to be constituted by
arrays of repeating DNA blocks that made the sequence particularly
prone to structural variation in the male population (Fig. 1; Kuroda-
Kawaguchi et al., 2001). These blocks were termed amplicons and
they correspond to large DNA sequences (range: 115–678 kb)
present in multiple copies in AZFc. Appropriately, the closely
packed arrangement of the amplicons forms a genetic lattice of unpre-
cedented complexity in the human genome. The AZFc amplicons are
organized in sequence families, each displaying a particular genetic sig-
nature. Most signiﬁcantly, intra-family sequence identity levels between
amplicon copies exceed 99.9%, making them prime substrates for
structural rearrangements. Five different families (colour-coded as
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blue, green, red, grey and yellow) map to the reference AZFc
sequence, harbouring a total of 13 different ampliconic units (Kuroda-
Kawaguchi et al., 2001). The functional relevance of this organization
stems from the fact that amplicons accommodate genes required
for spermatogenesis. Therefore, changes in amplicon copy number,
by implying gene dosage variation, can ultimately resound in phenoty-
pical modiﬁcations in the spermatogenic proﬁle.
AZFc gene content
The structural organization of the AZFc transcription units mimics the
complexities of the ampliconic architecture. Active copies of four
protein-coding gene families map to the AZFc interval: PRY2, BPY2,
DAZ and CDY1 (Fig. 1; Kuroda-Kawaguchi et al., 2001). These genes
locate to the blue, green, red and yellow-coded amplicons, respect-
ively, with one transcription unit per amplicon copy. As previously
stated, AZFc genes correspond to functional determinants of sperma-
togenesis, as evidenced by their germline-speciﬁc expression and by
the fact that their deletion conveys phenotypical consequences only
for the gametogenic tissue (Lahn and Page, 1999, 2002; Tse et al.,
2003; Stouffs et al., 2004; Huang et al., 2008; Kim et al., 2009). Still,
they cannot be considered essential for either spermatogenesis or
fertility, as illustrated by the frequent detection of mature sperm in
men with complete AZFc deletions and by the extremely rare cases
of natural transmission of AZFc deletions to the progeny (Vogt
et al., 1996; Chang et al., 1999; Cram et al., 2000; Saut et al., 2000;
Calogero et al., 2002; Gatta et al., 2002; Kuhnert et al., 2004; Xia
et al., 2006). However, the dramatic reduction in spermatogenic
output associated with complete AZFc deletions is a clear indicator
of their biological relevance. Since there are several reviews authorita-
tively characterizing the AZF genes (for selected reading: Yen, 2004;
Reynolds and Cooke, 2005; Vogt et al., 2008), such topic will fall
outside the scope of the present manuscript. Succinctly, available evi-
dence suggests that AZFc genes encode for germline-speciﬁc functions
in: (i) germ cell apoptosis (Stouffs et al., 2001, 2004), (ii) protein ubi-
quitination (Wong et al., 2002, 2004), (iii) transcriptional regulation
coupled to chromatin remodelling (Lahn et al., 2002; Caron et al.,
2003) and (iv) transport, storage and translational activation of devel-
opmentally regulated transcripts (Collier et al., 2005; Lee et al., 2006;
Kee et al., 2009). These have been ascribed to the PRY2, BPY2, CDY1
and DAZ genes, respectively. It should be noted that the last two
families also display autosomal homologues (Dorus et al., 2003; Rey-
nolds and Cooke, 2005). Therefore, some degree of functional redun-
dancy between the Y-borne and the autosomal copies may partially
account for the production of mature sperm in AZFc-deleted men.
Figure 1 Genomic organization of the AZFc region of the Y chromosome. (A) Schematic view of the Y chromosome. The pseudoautosomal
regions (PAR1 and PAR2) are depicted in light green and the euchromatic domains of the male-speciﬁc region of the Y in blue. The grey regions
represent heterochromatic sequences (cen ¼ centromere). The three AZF regions are mapped below the ideogram. (B) Structural architecture of
the reference AZFc region. AZFc is almost exclusively constituted by stretches of ampliconic units, each represented by block arrows. The AZFc
amplicons are divided into ﬁve colour-coded sequence families (yellow, blue, green, red and grey) with each unit being designated according to a
binomial notation indicative of family type and intra-family unit number. The length and orientation of the arrows represent amplicon size and polarity,
respectively. Organization of amplicons in symmetrical arrays of contiguous repeat units (palindromes P1 to P3) is depicted by large triangles above the
sequence. Single copy domains are indicated in white, although the spacers between the two red amplicon clusters are identical. (C) Mapping of the
AZFc genes to the ampliconic units. Solid triangles represent active transcription units and white triangles depict pseudogenes. Orientation refers to
5′ –3′ polarity. Please note the high gene density of the interval and the extensive pseudogenic content.
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Structural complexity of the AZFc sequence
The structural complexity of AZFc transcends that of a random assort-
ment of ampliconic units. In fact, amplicons can display a higher-order
level of architectural organization: they can be organized in symmetri-
cal arrays of contiguous units. These arrays are designated as palin-
dromes and are deﬁned by a symmetry axis separating two largely
identical arms constituted by single or multiple amplicons (Fig. 1;
Kuroda-Kawaguchi et al., 2001; Skaletsky et al., 2003). AZFc contains
two full palindromes (P1 and P2), as well as the distal end of P3,
accounting in total for 90% of the sequence (Kuroda-Kawaguchi
et al., 2001). The exact functional role played the ampliconic/palindro-
mic organization is not fully understood. The current view is that they
are an evolutionarily conserved strategy of the Y chromosome striving
for maintenance of genetic integrity in the coding domains (Skaletsky
et al., 2003; Lange et al., 2009). Considering that AZFc maps to the
male-speciﬁc region of the Y chromosome (and is therefore bereft
of homologous recombination with a chromosome partner), the func-
tional relevance of this model as a counter to the accumulation of
deleterious mutations is evident. Appropriately, the multiple gene
copies that map to the ampliconic domains may serve both as
buffer (via a copy number effect) and correction mechanism (via
gene conversion) against the build-up of such events. The establish-
ment of higher-order chromatin conﬁgurations arising from the palin-
dromic architecture has also lead to some speculation on their
involvement in lineage-speciﬁc modulation of transcriptional availability
and in meiotic sex chromosome inactivation (Vogt and Fernandes,
2003; Yogev et al., 2004; Geoffroy-Siraudin et al., 2007). Yet, exper-
imental evidence to validate either is still scarce.
It can be argued that the most prominent function imputable to the
ampliconic organization is the generation of genetic diversity. Seeing
that intra-family amplicon copies represent genomic domains of extre-
mely high sequence identity, they potentiate the occurrence of intra-
chromosomal homologous recombination (Repping et al., 2006;
Jobling, 2008; Lange et al., 2009). Available evidence indicates that
the scale of this diversity is considerable, as it will be discussed in
this review. In fact, AZFc should be regarded as a genetically
dynamic chromosomal niche home to frequent large-scale structural
rearrangements. These include not only shufﬂing of existing amplicons
(resulting in positional variants), but also changes to the overall
number and qualitative state of the sequences. Thus, by acknowled-
ging the extent of this diversity it becomes clear that the structural
organization of the reference AZFc sequence corresponds to one
out of a multitude of possible genomic states. In the following
section, the molecular mechanisms underlying AZFc genetic diversity
will be addressed. These will serve as a conceptual premise for a clini-
cally oriented analysis of the phenotypical effects associated with the
AZFc variants.
Generating genetic diversity:
recombination mechanisms
in AZFc
Since the mid 1980s, that polymorphisms in the Yq region later ident-
iﬁed as AZFc have been appreciated (Lucotte and Ngo, 1985;
Disteche et al., 1986). Yet, a more extensive measure of AZFc
genetic diversity in the Y chromosome population was only estab-
lished in 2006 (Repping et al., 2006). The latter study demonstrated
that AZFc rearrangements were one of the major motifs for
large-scale Y structural variation. Such variation stems from a high
mutation rate in the interval (≥3.8 × 1024, lower bound) and is illus-
trated by the detection of 11 different AZFc architectures in 47
chromosomes representing the major evolutionary branches of the
Y genealogy (Repping et al., 2006). This rate is particularly striking
when compared with the 2.3 × 1028 single nucleotide substitution
rate in the Y chromosome (for 25 year generations). It should be
noted that the recorded AZFc mutation rate represents a conservative
estimate since it refers solely to changes in the number or order of the
reference sequence amplicons. In this regard, more minute differences
or even the existence of entirely different amplicon families in the Y
genealogy may greatly enhance the scale of diversity. Thus, sequencing
AZFc across different Y evolutionary lineages, although a
daunting task, may shed new light on the genetic regulation of
spermatogenesis.
Given the lack of conventional recombination with a chromosome
partner, the use of amplicons as intrachromosomal recombination
substrates represents the major adaptive strategy adopted by AZFc
to ensure genetic variability (Yen, 2001; Repping et al., 2006; Lange
et al., 2009). Appropriately, the high sequence identity recorded
between intra-family amplicon copies provides a favourable context
for the activation of non-allelic homologous recombination pathways
(Sebat et al., 2004; Shaw and Lupski, 2004; Jobling, 2008). Nonethe-
less, the contribution of non-homology based mechanisms should
not be overlooked: AZFc retains evidence at the sequence level for
the actions of both homology and non-homology dependent
pathways.
Evidence for non-homology based
recombination
Even though the molecular origin of the majority of AZFc rearrange-
ments can be imputable to homology-based recombination, the analy-
sis of some variants suggests otherwise (Repping et al., 2004; Ferlin
et al., 2005; Hucklenbroich et al., 2005; Lynch et al., 2005; Premi
et al., 2007; Balaresque et al., 2008). In these cases, identifying the
exact mechanism is a complex task owing to a still limited knowledge
on non-homology based pathways and to difﬁculties in characterizing
the variants at the sequence level. Even so, indirect evidence support-
ing the activation of the non-homologous DNA end joining (NHEJ)
pathway can be identiﬁed in certain AZFc rearrangements (Repping
et al., 2002; Costa et al., 2008; Yang et al., 2008b). Brieﬂy, NHEJ cor-
responds to an enzyme-based DNA double strand break (DSB) repair
pathway promoting the rejoining of two DNA ends via untemplated
nucleotide gain or loss at the ligation site (for a review: Lieber,
2008). Since NHEJ is a non-homology based mechanism, it does not
require DNA pairing for successful ligation and, consequently, is
more frequent in non-duplicated regions (Argueso et al., 2008;
Robert et al., 2008). Yet, some repeat-heavy genomic domains
seem to potentiate the activation of NHEJ, as observed in the subte-
lomeric regions (Ribes-Zamora et al., 2007). Furthermore, the proces-
sing of the DNA ends can be inﬂuenced, in some cases, by the
establishment of short terminal homology domains (,25 nucleotides;
McVey and Lee, 2008; Pawelczak and Turchi, 2008). The involvement
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of NHEJ in AZFc deletions can be inferred from the presence of
deletion breakpoints displaying the addition of untemplated nucleo-
tides and ﬂanked by non-homologous sequences. Although the conﬁr-
mation warranted by breakpoint sequencing is still restricted to a few
cases, the analysis of previously published deletion patterns suggests
the contribution of NHEJ for some AZFb/AZFb + c deletions
(Repping et al., 2002; Costa et al., 2008; Yang et al., 2008b). This is
particularly evident in a deletion breakpoint ﬂanked by non-
homologous blue and yellow ampliconic sequences (Repping et al.,
2002). In this sample, both the fact that the deletion product could
not have arisen from homologous recombination and the addition of
untemplated nucleotides at the deletion junction are clear hallmarks
of the process.
On more general terms, given the extensive opportunity for
homology-based recombination provided by the amplicons, it can be
envisaged that the contribution of NHEJ (or other non-homologous
mechanisms) for AZFc variability may be marginal. Nonetheless, the
established practice of interpreting AZFc rearrangements under the
auspices of homology-based recombination (usually the most parsimo-
nious model) might further accentuate this bias.
Intrachromosomal homologous
recombination
Of the molecular repertoire available to AZFc, intrachromosomal
homologous recombination represents the key generator of genetic
variability. Recently, an encompassing model for homologous recom-
bination in the palindromic domains has been proposed (Lange et al.,
2009). According to this model, recombination is triggered by the gen-
eration of a DSB within an amplicon. The occurrence of such lesions
are particularly frequent in the male germline, owing to the fact that
spermatogenesis requires multiple cell divisions in an oxidative
environment depleted of DNA repair enzymes (Crow, 2000; Aitken
and Graves, 2002). How this DSB is resolved is the crucial parameter
in determining the genetic outcome of the process. If the crossover-
dependent pathway is activated, the sequence is modiﬁed by the
occurrence of a structural rearrangement. Yet, if the non-crossover
pathway is selected, modiﬁcation is restricted to a short sequence
that undergoes gene conversion. The balance between the two path-
ways largely dictates the type and degree of genetic heterogeneity in
AZFc.
Gene conversion
Gene conversion corresponds to the unidirectional transfer of genetic
material from a donor sequence to a homologous acceptor target (for
a review: Chen et al., 2007). The Y chromosome palindromes seem
particularly prone to this type of events, as available data points to
an estimate of 600 Y–Y converted nucleotides per generation, reﬂect-
ing a conversion rate of 2.8 × 1024 per duplicated base per 25-year
generation (Rozen et al., 2003). Using the upper limits of mean con-
version length (the latest ﬁgures point to averages of 300 converted
nucleotides per event), this corresponds to at least two distinct Y–
Y conversions per generation (Jeffreys and May, 2004; Benovoy and
Drouin, 2009). Although the exact molecular mechanisms for gene
conversion in the Y chromosome remain elusive, there is little
doubt of its relevance as a major modulator of AZFc genetic plasticity.
The analysis of amplicon-speciﬁc genetic tags (generally designated as
sequence family variants) has revealed not only that these events are
extremely frequent, but also that the majority of them are selectively
neutral in terms of reproductive ﬁtness (for selected reading: de Vries
et al., 2002; Repping et al., 2003a; Machev et al., 2004; Zhang et al.,
2006; Lin et al., 2007; Navarro-Costa et al., 2007; Giachini et al.,
2008; Stouffs et al., 2008). Interestingly, our results indicate that con-
version patterns reﬂect to some extent differences between Y
chromosome evolutionary lineages (Navarro-Costa et al., 2007).
This suggests that gene conversion may have played a role in the
establishment of lineage-speciﬁc AZFc genotypes. The consequences,
if any, of these evolutionary variants for the functional regulation of the
AZFc genes remain to be assessed.
Gene conversion has been proposed to serve as a genetic correc-
tion mechanism for ampliconic genes (Skaletsky et al., 2003; Lange
et al., 2009). Under this model, conversion displays a directional
bias favouring the replacement of defective coding sequences with
unaffected templates. Recent studies have revealed the existence of
highly directional conversion, arguing against the classic view of a
sequence having equal probability of serving as donor or acceptor
(Szostak et al., 1983; Bosch et al., 2004; Webster et al., 2005;
Dreszer et al., 2007). Seeing that the triggers for gene conversion
have only recently begun to be unravelled (Chuzhanova et al.,
2009), the drivers for such directionality remain elusive. DNA
sequence motifs are bound to play a crucial role in the process, yet
how the functional status of the sequence could inﬂuence one direc-
tion over the other is unclear. Thus, for the time being, proposing a
functional directionality for AZFc conversions corresponds to a specu-
lative effort. With or without bias, AZFc conversions are a clearly
bi-directional process as demonstrated in the CDY1 sequence
(Rozen et al., 2003). This means that the occurrence of diseases
associated with the replacement of active gene copies with defective
sequences have to be regarded as a trade-off in the gene correction
model (Bischof et al., 2006). Certainly, the extensive array of AZFc
pseudogene sequences can serve as fertile ground for such. It can
be argued that the loss of speciﬁc CDY1 sequence variants being sig-
niﬁcantly more frequent in infertile males than in controls partially
reﬂects this effect (Machev et al., 2004).
In light of these considerations, gene conversion should be regarded
as a signiﬁcant driver of AZFc variability, playing until clearly demon-
strated otherwise, a largely unpredictable role in the functional regu-
lation of the interval.
Deletions and other structural rearrangements
The activation of the crossover-dependent pathway to resolve a DSB
in the ampliconic domains results in a structurally rearranged chromo-
some. The type of the rearrangement depends on whether the
sequences display direct or inverted polarity and on the genetic
identity of the recombination intermediates (sister or non-sister
chromatids).
If the process involves intrachromatid intermediates displaying
inverted sequence polarity, it results in inversions (Lupski, 1998).
AZFc seems particularly prone to these rearrangements: an evident
bias for inversions is detected both in the main evolutionary branches
of the Y genealogy and in the minimum-mutation history of AZFc
(Repping et al., 2006). Even though inversions do not seem to
convey any speciﬁc functional consequences per se, they can serve
as substrates for the occurrence of AZFc deletion/duplications
AZFc region: from genetic diversity to male infertility 5
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(Fig. 2). Fittingly, the role of inversions in AZFc is generally perceived
as more of a generator of architectural diversity than of a phenotype
modiﬁer. It has been demonstrated that inversions to the reference
AZFc sequence are required as substrates for some deletions
(Fernandes et al., 2004; Repping et al., 2004), still it is currently
unknown whether they can actually increase the likelihood of sub-
sequent rearrangements. Seeing that in some populations partial
AZFc deletions have been shown to favour the occurrence of com-
plete deletions (Zhang et al., 2007; Lu et al., 2009), the existence of
an analogous effect for inversions is a tangible possibility. More
recently, the functional consequences of an interchromatid recombi-
nation between inverted Y chromosome sequences have been dis-
cussed (Lange et al., 2009). This mechanism results in the formation
of an isodicentric Y chromosome, a chromosomal variant associated
with severe clinical consequences ranging from spermatogenic failure
to sex reversal. The involvement of the AZFc palindromes in the gen-
eration of isodicentric Y chromosomes was not only conﬁrmed but
also identiﬁed as a risk factor for the development of female sexual
features due to increased mitotic instability.
Deletions represent one of the most functionally relevant struc-
tural rearrangements in AZFc (Fig. 2). Under normal conditions,
these are essentially the product of homologous recombination
between sequences sharing identical polarity (Lupski and Stankiewicz,
2005; Turner et al., 2008). Nevertheless, in populations subjected to
high levels of natural background radiation, less extensive AZFc del-
etions (arising from the frequent occurrence of DNA lesions) are
relatively commonplace (Premi et al., 2009). The clinical signiﬁcance
of AZFc deletions becomes evident when considering that they not
only represent one of the most frequent copy-number variants in the
human genome, but also that they can decisively impact male fertility
(Vogt, 2004; Krausz and Degl’Innocenti, 2006; Noordam and
Repping, 2006; Tyler-Smith, 2008). As previously discussed, AZFc
was ﬁrst deﬁned based on the phenotype associated with its com-
plete deletion (Vogt et al., 1996). The latter arises from recombina-
tion between the terminal b2 and b4 amplicons (b2/b4 deletions)
and leads to a dramatic reduction of spermatogenic output (Fig. 2;
Kuroda-Kawaguchi et al., 2001). Nevertheless, as a result of the intri-
cate sequence organization of the interval, AZFc deletions may be
less extensive and involve the internal amplicon units; such
rearrangements are referred to as partial deletions. Owing to their
high prevalence in the male population, these are the focus of par-
ticular interest among the andrological community. Interestingly,
despite a barrage of published reports, the debate still rages as to
whether or not they represent a risk of male infertility. Accordingly,
the following section will deal in detail with the divisive topic of
partial AZFc deletions.
Figure 2 Structural variants of the reference AZFc sequence. Most parsimonious recombination mechanisms using the reference sequence (centre)
as starting point are depicted. Variant nomenclature refers to the ampliconic units involved in the non-allelic homologous recombination event.
Although evidence for the existence of several other AZFc rearrangements has been published, only variants that have been validated by molecular
cytogenetics or AZFc sequencing approaches were included. The b2/b4 deletion corresponds to the complete AZFc deletion. Only one case of the
Gr1/Gr2 duplication has been reported (Repping et al., 2006), and the recombination mechanism is still tentative.
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Genetic and phenotypical
aspects of partial AZFc deletions
Unlike complete AZFc deletions, which are consensually regarded as a
causative agent of spermatogenic disruption, the clinical consequences
of partial deletions are far more difﬁcult to ascertain. This difﬁculty
arises from signiﬁcant phenotypical heterogeneity, as illustrated by
the frequent cases of normal sperm counts and/or deletion trans-
mission to the progeny in affected individuals (for illustrative examples:
Hucklenbroich et al., 2005; Lynch et al., 2005; de Carvalho et al., 2006;
Zhang et al., 2006; Navarro-Costa et al., 2007; Giachini et al., 2008).
The heterogeneities recorded for partial AZFc deletions reﬂect on
two different levels: (i) when comparing between different partial
deletion patterns and (ii) when analysing the phenotypical diversity
associated with a single pattern. Regarding the ﬁrst, it is acknowledged
that although some deletion types may represent a male infertility
risk, others do not (Fernandes et al., 2002; Repping et al., 2003b;
Fernandes et al., 2004; Repping et al., 2004; Balaresque et al.,
2008). As for the second, a striking variation in spermatogenic proﬁles
has been documented even for partial deletion patterns presumably
conveying an infertility risk (Lynch et al., 2005; Giachini et al., 2008;
Yang et al., 2008c; Krausz et al., 2009). Variation in these cases corre-
sponds to the full range of male gametogenic phenotypes as deﬁned in
terms of sperm number/concentration, morphology and motility. In
light of this tremendous plasticity, identifying robust genotype–
phenotype correlations is particularly complex. This is evidenced by
the multitude of conﬂicting reports on the effects of partial AZFc del-
etions on spermatogenesis (for an extensive list, please consult
Table I).
In this section, a critical view on previously published partial AZFc
deletion association studies will be undertaken. The objective of this
analysis is to present a uniﬁed picture based on a pondered evaluation
of the speciﬁcities of the selected data sets. By carefully curtailing
some aspects of inter-study heterogeneity, this approach may accent-
uate biological similarities and ultimately resound in novel insight on
the clinical consequences of partial AZFc deletions.
Methodological difﬁculties in the study
of partial AZFc deletions
As extensively discussed in several reviews, three main partial AZFc
deletion patterns have been identiﬁed: the b1/b3, b2/b3 and gr/gr
deletions (for selected reviews: Vogt, 2004; Krausz and Degl’Inno-
centi, 2006; Noordam and Repping, 2006; Sadeghi-Nejad and
Farrokhi, 2007). These remove between 1.6 and 1.8 Mb of the
region and reduce the overall dosage of the AZFc gene families
(Fig. 2). Besides these three, several other deletion types have been
reported. Yet, restricted numbers of identiﬁed cases still limit their
characterization (Ferlin et al., 2005; Hucklenbroich et al., 2005;
Lynch et al., 2005; Premi et al., 2007; Balaresque et al., 2008). Such
limitation is equally extensible to b1/b3 deletions, as attested by
their low frequency in the sampled populations (Repping et al.,
2003b; Hucklenbroich et al., 2005; Lynch et al., 2005; Stouffs et al.,
2008). Similar to that observed in complete AZFc deletions, men
with partial deletions do not seem to display any distinctive clinical
or hormonal features besides those associated with spermatogenic
deregulation. Nonetheless, although a previous association between
gr/gr deletions and increased risk of testicular germ cell tumour has
not been replicated in a geographically well-deﬁned population, it is
still too premature to draw deﬁnitive conclusions on this topic
(Nathanson et al., 2005; Ferlin et al., 2007a).
Non-allelic homologous recombination between internal AZFc
amplicons is considered the main mechanism responsible for the gen-
eration of partial AZFc deletions. Accordingly, partial deletion types
are deﬁned based on the identity of the amplicon units involved in
the recombination event. Since the gr/gr deletion displays a large
recombination target (the green–red–red amplicon blocks), genetic
heterogeneity in this deletion type is further accentuated by variation
in breakpoint localization. This heterogeneity may express itself in
functional terms if, as some authors suggest, the different AZFc
gene copies may vary slightly in regulation (Fernandes et al., 2002;
Machev et al., 2004; Ferlin et al., 2005; Giachini et al., 2005). Never-
theless, even though an amplicon-speciﬁc characterization of gr/gr del-
etion products (a process designated as partial deletion sub-typing)
conﬁrms genotypical diversity, we have been unable to establish deﬁni-
tive genotype–phenotype correlations for these sub-types (Navarro-
Costa et al., 2007). Indeed, the similar distribution of deletion sub-
types between men with normal and abnormal sperm parameters
suggests this degree of variation is insufﬁcient to explain the consider-
able phenotypical heterogeneity attributed to partial deletions (Krausz
et al., 2009). In addition, although it has been hypothesized that the
autosomal copies of the DAZ and CDY1 genes can exert some
degree of modulation on the phenotypical outcome of such deletions,
no evidence to substantiate this claim has yet been recorded (Giachini
et al., 2005; Chen et al., 2009). However, a recent indication that the
germline DNA demethylation pattern of the DAZ gene is under strin-
gent control (Navarro-Costa et al., unpublished results) suggests that
epigenetic disturbances in AZFc may be a likely phenotype modulator.
Regarding the functional consequences of partial AZFc deletions,
published reports veer between those detecting an association with
spermatogenic failure (albeit in the form of a risk factor and not as cau-
sative agent) and those that do not. Several authors have already dis-
cussed in general terms the theoretical bases for inter-study
inconsistencies in the outcome of genetic association tests. Most
point out that initial associations tend not to be replicated by sub-
sequent reports (Ioannidis et al., 2001; Vieland, 2001; Trikalinos
et al., 2004). In the majority of cases, heterogeneity increases in par-
allel with the publication of additional studies, until an adequately
powered meta-analysis ultimately rebukes the initial association. It
has been argued that such heterogeneities stem more from methodo-
logical issues than from actual biological differences between the
queried populations (Colhoun et al., 2003). This matter is particularly
pressing in the context of partial AZFc deletions since sample inclusion
criteria vary considerably between reports. Several studies use normo-
zoospermic men as controls, others use fertile men with unknown
spermatogenic status and some even use a mix of both. Seeing that
partial AZFc deletions have been linked to spermatogenic impairment,
the use of normozoospermic men as controls is a more appropriate
option. Yet, it should be noted that some authors have identiﬁed an
association between partial deletions and male infertility despite
normal spermiogram parameters (Lynch et al., 2005; Wu et al.,
2007). Variations in selection criteria are also patent in the cases
group. Although most of the published reports use reduced sperm
concentration (irrespective of other spermiogram data) as the key
AZFc region: from genetic diversity to male infertility 7
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Table I Main study parameters of the selected case–control reports on the association of gr/gr deletions with spermatogenic disruption/male infertility.
Pub. date Authors Population Controls Cases Del.
conﬁrmationc
Gene
dosage
Y
haplogroup
matchingd
Other remarks
Total n Tested
for NZa
gr/gr
del.
Stated exclusion
criteria
Total n Sperm
conc.
distrib.b
gr/gr
del.
Association
2003 Repping et al. Dutch 148 100% 0.0% – Abnormal karyotype
– AZF deletions
– Other causes for
spermatogenic failure
246 n/a 3.7% FISH Yes Yes None
2004 de Llanos et al. Spanish 232 15% 0.0% – Abnormal karyotype
– AZF deletions
283 Azo: 23%;
,5 M:
77%
4.2% None No No Exclusion criteria not tested for all
samples
2005 Ferlin et al. North Italian 263 100% 0.4% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
337 Azo: 22%;
,20 M:
78%
4.7% None No No Cases display an over-estimation of del.
rates due to inclusion of gr/gr deleted
siblings
2005 Giachini et al. Italian 189 100% 0.5% – Abnormal karyotype
– AZF deletions
– Severe andrological
abnormalities
150 n/a 5.3% Gene dosage
PCR
Yes No 41% of cases with mild abnormal
andrological ﬁndings (varicocele,
monolateral cryptorchidism and/or
recurrent infections)
2005 Lynch et al. Australian 234 57% 0.4% Not stated 546
(ART)e
Azo: 21%;
,20 M:
79%
4.8% None No No – Recalculated rates (to remove
normozoospermic infertile males
and men with complete AZF
deletions)
– Idiopathic infertility not conﬁrmed in
25% of the ART cases
Abnormal karyotype 607
(databank)f
Azo: 32%;
,20 M:
68%
3.8%
2007 Navarro-Costa
et al.
Portuguese 300 0% 1.0% – Abnormal karyotype
– AZF deletions
– Other causes for
spermatogenic failure
300 Azo: 30%;
,10 M:
70%
5.0% DNA blotting No No None
2007 Yang et al. Han Chinese 262 100% 5.3% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
– Other causes for
spermatogenic failure
414 Azo: 59%;
,10 M:
41%
10.6% None No Yes None
2008 Yang et al. Han Chinese 634 100% 5.1% Same as above 1286 n/a 10.0% None No Yes Possible inclusion of samples from a
previous study (Yang et al., 2007)
2008 Giachini et al. Central Italian 487 100% 0.4% – Abnormal karyotype
– AZF deletions
– Non-central Italian
origin
– Varicocele grade ≥2
– Other causes for
spermatogenic failure
556 Azo: 13%;
,20 M:
87%
3.2% Gene dosage
PCR
Yes Yes – 30% of samples had been included in
a previous study (Giachini et al.,
2005)
– 49% of cases with mild abnormal
andrological ﬁndings (unilateral
varicocele grade ,2 and/or
previous infections)
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No association
2004 Machev et al. French 189 2% 2.1% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
254 ,0.1 M:
37%;
,5 M:
63%
3.9% – Gene dosage
PCR
– FISH
Yes No – Recalculated rates (to remove
normozoospermic infertile males)
– Admixed population
2004 Hucklenbroich
et al.
German 170 100% 1.8% – Abnormal karyotype
– AZF deletions
– Non-idiopathic oligo/
azoospermia
348 Azo: 18%;
,20 M:
82%
4.0% None No No Statistical difference only for b2/b3 del
2006 Ravel et al. Admixed 181 9% 3.3% – Cytogenetic
abnormalities
– AZF deletions
– Known causes of
infertility
192 All ,2 M 2.1% None No No Cases with mixed ethnic background
2006 Fernando et al. Sri Lankan 87 100% 4.6% Not stated 89 Azo: 82%;
,20 M:
18%
4.5% None No No Recalculated rates (to remove men with
complete AZF dels)
2006 Zhang et al. Han Chinese 89 100% 10.1% Not stated 87 Azo: 56%;
,20 M:
44%
10.3% Gene dosage
PCR
Yes Yes None
2006 Carvalho et al. Brazilian 122 0% 2.5% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
110 All Azo. 4.5% None No No Recalculated rates (to select fertile men
as controls)
2006 de Carvalho
et al.
Japanese 56 0% 33.9% Not stated 78 Azo: 63% 23.9% None No No – Population effect: all dels. in
haplogroup D2
– Controls with unknown fertility
status
– 37% of cases with no biopsy data
– Recalculated rates (to remove
infertile males with complete AZF
dels. and no biopsy data)
2007 Zhang et al. Han Chinese 280 32% 7.1% Not stated 296 Azo: 73%;
,20 M:
27%
8.1% Gene dosage
PCR
Yes Yes Possible inclusion of samples from a
previous study (Zhang et al., 2006)
2007 Wu et al. Han Chinese 248 35% 7.7% – Abnormal karyotype
– Obstructive
azoospermia
– Cryptorchidism
– Secondary sterility
218 Azo: 66%;
,20 M:
34%
6.9% None No No – Statistical difference only for b2/b3
del.
– Recalculated rates (to remove men
with complete AZF dels. and cases
without spermatogenic impairment)
2007 Lin et al. Han Chinese
(in Taiwan)
107 0% 2.8% Not stated 142 All .0 and
,20 M
7.0% – Gene dosage
PCR
– DNA blotting
Yes Yes Despite the very distinct gr/gr del.
rates, statistical difference was only
recorded for the gr/gr duplic.
2007 Lardone et al. Chilean 77 40% 2.6% – AZFc deletions
– Hypogonadotrophic
hypogonadism
– Hypoandrogenism
– Chronic diseases
93 Azo: 67%;
,5 M:
33%
2.2% None No No – Recalculated rates (to remove men
with complete AZF dels)
– Confounding factors in controls
Continued
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Table I Continued
Pub. date Authors Population Controls Cases Del.
conﬁrmationc
Gene
dosage
Y
haplogroup
matchingd
Other remarks
Total n Tested
for NZa
gr/gr
del.
Stated exclusion
criteria
Total n Sperm
conc.
distrib.b
gr/gr
del.
2007 Imken et al. Moroccan 176 43% 4.0% Not stated 123 Azo: 36%;
OAT: 64%
5.7% None No No Recalculated rates (to remove men with
complete AZF dels. and cases with
normal sperm counts)
2008 Stouffs et al. Admixed 394 71% 3.0% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
187 Azo: 24%;
,20 M:
76%
4.3% None No No Population: Caucasian males living
either in Belgium or in the Netherlands
2008 Ravel et al. Admixed 193 57% 6.7% – Abnormal karyotype
– AZF deletions
– Obstructive
azoospermia
– Other causes for
spermatogenic failure
364 Azo: 32%;
,20 M:
68%
4.1% – Gene dosage
PCR
– DNA blotting
Yes No – Cases with mixed ethnic background
– Includes samples from a previous
study (Ravel et al., 2006)
Values in bold highlight gr/gr deletion rates in cases and controls.
aPercentage of normozoospermic controls (NZ), as conﬁrmed by sperm parameters. In the remaining individuals no semen analysis was performed.
bSperm concentration distribution. Azo, Azoospermia; OAT, oligoasthenoteratozoospermia; M, million sperm/ml.
cDeletion conﬁrmation (of the PCR result) via complementary molecular cytogenetics, DNA blotting or gene dosage methods.
dAs conﬁrmed by haplogroup typing in cases and controls.
eSample set corresponds to consecutive infertile males with idiopathic spermatogenic failure enrolled in an ART programme.
fSample set corresponds to a selection of infertile men with spermatogenic failure retrieved from the Monash Male Infertility database.
n/a, not available.
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parameter, the exact cut-off value varies. Additionally, the inclusion of
variable fractions of azoospermic men and the presence of secondary
clinical features related (or not) to the infertility phenotype also favour
the observed heterogeneities.
On a more general note, it is obviously advantageous in terms of
association strength to enforce stringent selection criteria in order
to ensure a greater homogeneity of the tested population. Neverthe-
less, even if factors directly attributable to study design are largely con-
trolled, the outcome of partial AZFc deletion association studies may
vary greatly, as illustrated by two reports published on Han Chinese
men.
Illustrating heterogeneity: the Han Chinese results
In 2007, two association studies on the effects of partial AZFc del-
etions on spermatogenesis were published weeks apart in two well-
renowned journals (Wu et al., 2007; Yang et al., 2008c). What
made these reports particularly interesting was that both tested the
same population (Han Chinese men) using similar analytical tools.
Seeing that both were published almost simultaneously, possible inﬂu-
encing effects were unlikely. In this regard, they present an ideal
opportunity to assess the intrinsic variability associated with this
type of study, even more so since their conclusions could not have
been more disparate: although Yang et al. identiﬁed an association
with spermatogenic failure in gr/gr but not in b2/b3 deletions, an
opposite association was recorded by Wu et al. What could explain
such dramatic differences in two similar reports?
Although both studies analysed the Han Chinese ethnic group,
subjects were recruited from two different areas (Eastern and
South-western China) distancing 1500 km. Whereas this may
seem trivial, geographical differences can exert a signiﬁcant effect
on the outcome of Y chromosome association tests. The notion
of Y haplogroup is central to this discussion. A chromosomal hap-
logroup refers to a group of chromosomes sharing a similar combi-
nation of binary allelic states at multiple loci (for a review: Jobling
and Tyler-Smith, 2003). Such a combination is designated as a hap-
lotype and serves as a genetic identiﬁer. The lack of a recombina-
tion partner in the male-speciﬁc region of the Y implies that these
allelic states are passed largely intact from generation to generation,
thus representing an ideal tool for the construction of a Y phylo-
geny (Y Chromosome Consortium, 2002). In fact, thanks both to
social and evolutionary factors, the Y haplogroups display very
speciﬁc patterns of geographical clustering, allowing the deﬁnition
of male populations based on haplogroup composition (Fig. 3; Seiel-
stad et al., 1998; Tyler-Smith, 2008).
It has been demonstrated that gr/gr deletions are ﬁxed in hap-
logroups D2 and Q1, and b2/b3 deletions in haplogroup N, although
a proximal AZFc deletion is presumably ﬁxed in haplogroup C3*
(Repping et al., 2003b; Fernandes et al., 2004; Repping et al., 2004;
de Carvalho et al., 2006; Zhang et al., 2007; Balaresque et al., 2008).
Since these Y lineages are signiﬁcantly prevalent in several populations,
it is considered that the deletion’s deleterious effect on fertility has been
countered by lineage-speciﬁc compensatory factors. Thus, the overall
detection of an association between partial AZFc deletions and sperma-
togenic impairment for a given population depends on its haplogroup
composition, particularly on the frequency of these deletion-ﬁxed
lineages, as they will dilute a theoretical risk present in other
Figure 3 World distribution of Y chromosome haplogroups. The major evolutionary lineages are depicted by the A to T nomenclature of the Y
Chromosome Consortium, with the position of the identiﬁers corresponding to the geographic region where the haplogroup originated or where
prevalence is high. Haplogroup P* due to its minimal distribution is not shown. Arrows represent an abridged outlook into the major Y haplogroup
migration events. Red identiﬁers indicate the ﬁxation of partial AZFc deletions in some of the lineages constituting the haplogroup. Their extensive
dissemination suggests that partial AZFc deletions in these evolutionary backgrounds do not convey phenotypical consequences for male fertility.
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haplogroups. In the speciﬁc case of the two Han Chinese studies,
although Yang et al. recorded statistically similar b2/b3 deletion rates
of 6 and 3% in controls and cases, respectively; such rates were of
3 and 9% in the Wu et al. report. Seeing that b2/b3 deletions are
ﬁxed in haplogroupNwith no apparent effects on fertility, a variable fre-
quency of this haplogroup in the two populations may partly account for
the recorded differences. Indeed, Yang et al. demonstrated that 80%
of their recorded b2/b3 deletions belonged to haplogroup N. Given
such a high contribution of this haplogroup (where the deletion
conveys no functional meaning) to the b2/b3 deletion pool, the lack
of association with spermatogenic failure reported in this study is not
surprising. On the other hand, the study of Wu et al. did not include
full haplogroup typing. It can be speculated that their studied population
exhibited lower frequencies of haplogroup N and a concomitant
increase of other Y lineages where the effects of the b2/b3 deletion
could indeed be associated with spermatogenic failure. Actually, this
geographic effect may not only explain the divergent results observed
for b2/b3 deletions but also account for discrepancies in gr/gr deletion
rates. These were similar between controls and cases in the Wu et al.
study (8 and 7%, respectively), but varied signiﬁcantly in that of
Yang et al. (5 and 11%). In the study reporting an association, 31%
of gr/gr deletions occurred in haplogroup Q1, where this deletion is
ﬁxed. Since for this particular haplogroup, no signiﬁcant differences in
deletion rates were recorded between cases and controls, as expected,
the detected association must have stemmed from the contribution of
other haplogroups. A hypothetical increase in haplogroup Q1 preva-
lence in East China, by masking the actual association present in the
other haplogroups, could thus explain the lack of association reported
by Wu et al.
The Han Chinese reports serve as a prime example of how slight
differences in study settings can empathically alter the end result of
an association test. Even though some minor heterogeneities in selec-
tion criteria were patent, the contrasting results are most likely the
consequence of geographical speciﬁcities of the tested populations.
In this regard, population dynamics have to be considered a prominent
driver for the recorded variability in AZFc association studies. Under
such an assumption, the impact of partial AZFc deletions on male
(in)fertility will vary depending on the evolutionary lineage of the
chromosome where they occur.
Y chromosome evolutionary lineages
and partial AZFc deletions
The inﬂuence exerted by Y evolutionary lineages on partial AZFc del-
etion dynamics may transcend that recorded in the deletion-ﬁxed hap-
logroups. In fact, other haplogroups seem to be able to modulate the
degree of spermatogenic disruption associated with partial deletions.
Appropriately, haplogroups C and DE* are signiﬁcantly more rep-
resented in gr/gr deleted Chinese men with spermatogenic failure
than in equally deleted normozoospermic males (Yang et al.,
2008c). It should be noted that this effect was not detected for b2/
b3 deletions nor it was replicated in a different regional context. In
fact, Krausz et al. (2009) found no evidence for distinct haplogroup dis-
tributions when analysing gr/gr deleted men with varying spermiogram
parameters recruited from European centres. Nonetheless, our pre-
vious results suggest that Y lineages, as deﬁned at the more detailed
haplotype level, might inﬂuence the phenotypical expression of
identical gr/gr deletion genotypes (Navarro-Costa et al., 2007). If suit-
ably validated, this observation may shed new light on possible func-
tional speciﬁcities of the different Y lineages.
Additionally, susceptibility to the occurrence of partial AZFc del-
etions seems to vary between Y haplogroups. Haplogroups C and
DE* have been associated with increased rates of partial deletions in
the Chinese population (Yang et al., 2008a). Thus, these haplogroups
convey an increased propensity for the occurrence of partial AZFc
deletions, as well as for spermatogenic failure whenever they are
present. Furthermore, haplogroups C and G are also particularly
prone to partial deletions affecting the proximal AZFc domain (Balar-
esque et al., 2008). An analogous effect but regarding the complete
AZFc deletion has been observed on a precisely deﬁned European
population (North Italy): a signiﬁcant over-representation of hap-
logroup E was identiﬁed in deleted men (Arredi et al., 2007). Inversely,
some suggestions for a protective effect have been proposed for hap-
logroups O3*, J and R (Arredi et al., 2007; Balaresque et al., 2008;
Yang et al., 2008a).
Globally, the published results illustrate the complex relationship
between Y evolutionary lineages, AZFc rearrangements and sperma-
togenic phenotype. It seems safe to assume that the evolutionary
history of the Y chromosome may modulate the phenotypical
expression of partial AZFc deletions via the lineage-speciﬁc acquisition
of genetic factors. Yet, until the nature of such auxiliary factors and
their actual contribution to the spermatogenic network are fully
understood, our knowledge of the intersection between Y evolution
and male infertility is restricted to the less than uniﬁed picture pre-
sented by the currently available association studies.
Partial AZFc deletion association studies:
an integrated approach
Different strategies have previously been employed in order to gain a
more cohesive outlook on partial AZFc deletion association studies.
Using a meta-analytic approach, two independent groups have ident-
iﬁed a signiﬁcant association between gr/gr deletions and male infer-
tility/spermatogenic disruption (Tuttelmann et al., 2007; Visser
et al., 2009). Yet, seeing that the available association studies display
remarkable variation in methods, sample selection criteria and geo-
graphical origin (Giachini et al., 2008), a comparative analysis of the
published reports is required if the bases for the inter-study
outcome differences are to be identiﬁed. To characterize this
aspect, we selected 23 association studies based on the criteria
stated in the methods section. Studies were divided between those
reporting an association between gr/gr deletions and spermatogenic
disruption/male infertility (9 studies) and those that did not (14
studies), followed by a pondered analysis of methodological design
speciﬁcities. The latter ensured that deletion rates were recalculated,
whenever necessary, so as to ensure greater inter-study homogeneity.
For a summary of the main parameters of the selected reports, please
consult Table I.
gr/gr deletions
Globally, 7500 men (2560 controls and 4961 patients) were ana-
lysed in the studies reporting an association compared with 5000
(2188 controls and 2867 patients) in those that did not. An interesting
observation pertains the publication year of the reports: for the ﬁrst
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3 years starting from initial identiﬁcation of the gr/gr deletion, ﬁve
independent studies reported an association (Repping et al., 2003b;
de Llanos et al., 2005; Ferlin et al., 2005; Giachini et al., 2005;
Lynch et al., 2005) against only two that did not (Machev et al.,
2004; Hucklenbroich et al., 2005). Nevertheless, from 2006
onwards this balance shifted signiﬁcantly to 4 (Navarro-Costa et al.,
2007; Giachini et al., 2008; Yang et al., 2008a, c) against 12 (Carvalho
et al., 2006; de Carvalho et al., 2006; Fernando et al., 2006; Ravel
et al., 2006; Zhang et al., 2006; Imken et al., 2007; Lardone et al.,
2007; Lin et al., 2007; Wu et al., 2007; Zhang et al., 2007; Stouffs
et al., 2008; Ravel et al., 2009). The main difference between
pre-2006 and post-2006 studies was the geographic origin of the
sampled populations. The ﬁrst wave of studies was mostly conducted
in European populations while the latter was more Asian-centric. In
fact, when analysing sample geographic origin, six of the nine studies
reporting an association were conducted on non-admixed European
populations, whereas this ﬁgure drops to 2 out of 14 in reports indi-
cating no association. Fittingly, the regional origin of the tested
population is a major factor modulating deletion frequency: in
studies where an association was reported, gr/gr deletion rates in
controls were under 1% except in the two non-European populations
(5.1 and 5.3% for Asian sample sets). This was equally reﬂected in the
patient group, as deletion frequencies were of 4.5% for Europeans
against 10.0 and 10.6% for studies conducted on Asian populations.
Interestingly, the deletion frequency in the control group largely dic-
tated the detection of the association. The range for this parameter
was 0–5% in studies reporting an association compared with1.8–
33.9% in those that did not. As before, a population geographical
origin effect was clearly observable: deletion rates in controls were
similar to those recorded in the patient group for the African and
Asian populations (bar the Taiwanese), while the South American
and European populations had lower rates that were nevertheless
insufﬁcient for the establishment of an association.
The observed regional variability can be explained by population-
speciﬁc genetic differences in Y chromosome constitution that need
to be taken into consideration when performing AZFc deletion diag-
nosis. Indeed, despite recent developments on microarray-based diag-
nostic platforms (Osborne et al., 2007), the PCR ampliﬁcation of a
genomic marker initially identiﬁed in the reference AZFc sequence
remains the most reliable and cost-effective genetic test for gr/gr del-
etions (Repping et al., 2003b). This sequence belongs to haplogroup R,
a predominant lineage in European populations (Brion et al., 2005). In
other lineages the absence of this marker may not be synonymous
with deletion, as previously observed in haplogroup J (Machev et al.,
2004), or the deletion may not convey a deleterious effect due to
presence of compensatory factors, as in the case of haplogroups Q1
and D2 (de Carvalho et al., 2006; Zhang et al., 2007; Lu et al.,
2009). Since the latter are under-represented in European populations
but predominant in others (Fig. 3), this can largely explain the apparent
regional clustering of the positive association studies. Consequently,
we can assume that the relevance of these deletions for male fertility
will vary geographically. This is suitably illustrated in the meta-analysis
of Visser et al. that identiﬁed a higher likelihood of spermatogenic
impairment in gr/gr deleted European populations when compared
with Asian counterparts (average OR 6.17 versus 1.84). It should
also be noted that the recommended diagnostic test for gr/gr del-
etions does not preclude conﬁrmation via adequate gene dosage
and/or copy type identiﬁcation assays, as a 5% misdiagnosis rate has
been recorded in a large multicenter study (Krausz et al., 2009).
Another controversial aspect is the exact deﬁnition of the clinical
risk associated with gr/gr deletions. In the vast majority of studies
reporting an association, gr/gr deletions are presented as a risk
factor for spermatogenic failure. Yet, one particular report has
suggested that infertility, not decreased sperm production, is the
main associated phenotype (Lynch et al., 2005). Lynch et al. base
their assumption on the analysis of normozoospermic infertile men,
arguing that the disruption introduced by gr/gr deletions may corre-
spond to a ﬁne-scale defect not assessable in a routine spermiogram.
Given the role in chromatin remodelling and cytoskeletal regulation
attributed to the CDY1 and BPY2 genes (Lahn et al., 2002; Wong
et al., 2004), it is tempting to speculate that either could contribute
to this hypothetical deregulation. Indirect evidence supporting these
claims has been recorded for another AZFc rearrangement. Accord-
ingly, a link to male infertility and not to low semen quality has been
identiﬁed for the b2/b3 deletion (Wu et al., 2007). Yet, a recent
cross-sectional cohort study reported signiﬁcantly lower sperm con-
centration, total sperm count and total motile sperm count in gr/gr
deleted men when compared with non-deleted individuals (Visser
et al., 2009). Even though this result indicates that gr/gr deletions
affect sperm numbers, the median concentration scores in both
groups were still within the normozoospermia range. Such an obser-
vation does not formally exclude the possibility that the actual
impact of gr/gr deletions may surpass that of a quantitative reduction
in spermatogenic output.
b2/b3 deletions
Unlike that observed for gr/gr deletions, the initial studies on b2/b3
deletions failed to identify any link to spermatogenic failure (Fernandes
et al., 2004; Repping et al., 2004). This was largely the consequence of
a signiﬁcant prevalence of the deletion-ﬁxed haplogroup N in the
sampled European populations. However, a subsequent study con-
ducted on Asian men identiﬁed an association between b2/b3 del-
etions and male infertility, irrespective of sperm counts (Wu et al.,
2007). More recently and after increasing sample numbers, the
same team has restricted the risk to spermatogenic impairment (Lu
et al., 2009). These results suggest that the occurrence of b2/b3 del-
etions outside of haplogroup N may represent a risk factor for sper-
matogenic impairment. Indeed, some indirect observations partially
corroborate the proposition: the most recent results of Lu et al.
(2009) demonstrate that while 80% of the b2/b3 deletions occurring
in fertile normozoospermic men belong to the deletion-ﬁxed hap-
logroup N, this fraction decreases to 65% when considering infertile
men. Furthermore, another study has identiﬁed a clustering (although
statistically non-signiﬁcant) of b2/b3 deletions to infertile men enrolled
in ART programmes (Mau Kai et al., 2008). Despite this tentative evi-
dence, an unambiguous link between b2/b3 deletions in speciﬁc Y
lineages and spermatogenic failure remains to be validated.
A propensity for the complete AZFc deletion has been identiﬁed in
the b2/b3 deletion-ﬁxed haplogroup N (Zhang et al., 2007; Lu et al.,
2009). Since a similar observation had been recorded for the gr/gr del-
etion in haplogroup Q1 (Zhang et al., 2007), this supports the theory
that speciﬁc AZFc architectures may predispose to subsequent
rearrangements. It has been suggested this propensity is higher in b2/
b3-deleted than in gr/gr-deleted backgrounds, although the exact
AZFc region: from genetic diversity to male infertility 13
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molecular mechanisms driving this effect remain elusive (Lu et al., 2009).
The occurrence of duplications also seems to be potentiated both by
b2/b3 and gr/gr deletions, as illustrated by the increased frequency
of DAZ gene copy duplications in deletion-ﬁxed lineages (Lin et al.,
2007). Taking into account these observations, the existence of struc-
tural AZFc triggers potentiating subsequent rearrangements have to
be considered. It can be envisaged that the chromatin conﬁgurations
associated with some architectures may alter the free energy state of
the DNA molecule. These may favour the occurrence of more thermo-
dynamically stable conﬁgurations via subsequent rearrangements, as
identiﬁed for autosomal palindromes (Gotter et al., 2007). In this
context, b2/b3 deletions may represent not only a presumable risk
factor for spermatogenic impairment when present in speciﬁc Y
lineages, but also a driver for genetic variability in the interval.
Dynamics of partial AZFc duplications
The genotypical and phenotypical characterization of partial AZFc
duplications is limited by a signiﬁcant under-reporting of these cases.
The prevailing view is that both partial and complete AZFc dupli-
cations do not represent any particular risk for spermatogenic
failure since the homeostatic mechanisms regulating spermatogenesis
can compensate, to some extent, imbalances associated with gene
dosage increases (Bosch and Jobling, 2003; Sebat et al., 2004; Giachini
et al., 2008). Appropriately, an early report identiﬁed a similar distri-
bution of partial duplication products between fertile and infertile
men (Writzl et al., 2005). Furthermore, no evidence of qualitative
and quantitatively increased spermatogenic output has been recorded
in men with AZFc duplications (Giachini et al., 2008; Krausz et al.,
2009). Interestingly, duplications restoring original gene copy
number after a partial deletion event fail to exert any noticeable
rescue effect on spermatogenic parameters (Krausz et al., 2009).
This supports the view that gene dosage imbalances alone are insufﬁ-
cient to account for the spermatogenic disruption associated with
partial AZFc deletions.
Nonetheless, a fairly recent study conducted in Taiwanese men
identiﬁed an association between partial AZFc duplications and sper-
matogenic failure (Lin et al., 2007). This ﬁts with previous data
suggesting that AZFc structural variability is rather conservative
regarding gene copy number (Repping et al., 2006). The link
between partial AZFc duplications and spermatogenic impairment
was later replicated in Han Chinese men from East China, but not
in Italian men (Zhang et al., 2007; Giachini et al., 2008). These
results imply that if increased AZFc gene content is to play a role in
spermatogenic impairment, the effect, much like that of the corre-
sponding partial deletions, will probably be modulated by population-
speciﬁc factors. In this regard, the Y haplogroup composition of the
studied population may be once again pivotal for the outcome of
the association test.
Concluding remarks
Genetic diversity is a cornerstone of life. Given the lack of canonical
recombination with a chromosome partner, such diversity is a difﬁcult
proposition in the male-speciﬁc region of the Y chromosome. Never-
theless, the ampliconic organization, by providing an ample substrate
for homology-based intrachromosomal recombination, represents
the major driver for genotypical heterogeneity in AZFc. In this
regard, two major evolutionary roles may be ascribed to the AZFc
amplicons: (i) the generation of novel genetic variants that may
confer some degree of selective advantage (even though selection is
particularly weak and diffuse in the Y chromosome); and (ii) the main-
tenance of the functional integrity of AZFc genes via conversion and/
or dosage mechanisms. Paradoxically, this strategy threads a precar-
ious equilibrium since the generation of dosage-imbalanced chromo-
somes, as in the case of AZFc deletions, and the
conversion-mediated replacement of functional alleles with affected
copies are inevitable by-products. Since both may decisively impact
the functional regulation of spermatogenesis as well as promote the
genetic degeneracy of the Y, the consequences of this strategy for
the evolutionary fate of the chromosome remains an open question.
Owing both to their considerable frequency in the infertile popu-
lation and ambiguous clinical signiﬁcance, partial AZFc deletions are
the most intensely debated AZFc variants. It has been argued that
routine diagnosis for such deletions is not recommended due to its
limited diagnostic value and the largely unknown consequences
these deletions convey to the well being of the progeny (Stouffs
et al., 2008). However, as thoroughly discussed in this review, these
deletions are clearly associated with spermatogenic impairment in
several geographically deﬁned populations. More speciﬁcally, although
in some European and Oceania populations the risk is considerable,
the deletion conveys no obvious clinical signiﬁcance in most Asian
and some Northern European populations. Since Y haplogroup com-
position is the main factor dictating the population-dependent
response, a thorough analysis of their distribution in our increasingly
globalized society may offer an ever more gentriﬁed outlook on the
impact of partial AZFc deletions for male fertility. Taking into con-
sideration all available data, we postulate that both gr/gr and b2/b3
partial deletions when occurring outside of Y haplogroups where
either deletion has become ﬁxed, represent an infertility risk. In that
context, their identiﬁcation is advantageous both for the elucidation
of the molecular aetiology of the infertility phenotype and for
genetic counselling in terms of deletion transmission to the progeny.
This latter issue is of particular importance since the severity of the
spermatogenic impairment defect in the male progeny is impossible
to predict, and most signiﬁcantly, partial deletions have been linked
to an increased propensity for the more deleterious complete AZFc
deletion. Therefore, partial AZFc deletion screening should be
regarded as an advantageous tool in the work-up of infertile
couples, provided it is performed in clinically informative populations
as deﬁned by their Y haplogroup composition.
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